Indoco Remedies Limited (BOM:532612)
India
· Delayed Price · Currency is INR 245.00
-3.60 (-1.45%)
At close: May 28, 2025
Indoco Remedies Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 16,413 | 18,173 | 16,686 | 15,408 | 12,415 | Upgrade
|
| Other Revenue | 236.3 | - | - | - | - | Upgrade
|
| Revenue | 16,649 | 18,173 | 16,686 | 15,408 | 12,415 | Upgrade
|
| Revenue Growth (YoY) | -8.38% | 8.91% | 8.30% | 24.10% | 12.20% | Upgrade
|
| Cost of Revenue | 4,982 | 6,204 | 5,661 | 4,946 | 3,842 | Upgrade
|
| Gross Profit | 11,667 | 11,969 | 11,025 | 10,461 | 8,574 | Upgrade
|
| Selling, General & Admin | 3,941 | 4,618 | 3,941 | 3,421 | 3,176 | Upgrade
|
| Research & Development | 760.1 | 971.57 | 809.7 | 746.42 | 597.04 | Upgrade
|
| Other Operating Expenses | 5,974 | 3,925 | 3,399 | 3,001 | 2,390 | Upgrade
|
| Operating Expenses | 11,813 | 10,435 | 8,856 | 7,954 | 7,059 | Upgrade
|
| Operating Income | -145.8 | 1,534 | 2,169 | 2,507 | 1,514 | Upgrade
|
| Interest Expense | -662.3 | -370.79 | -237.5 | -164.58 | -210.41 | Upgrade
|
| Interest & Investment Income | - | 39.59 | 5.85 | 4.77 | 7.95 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 9.82 | 2.43 | 32.9 | -1.62 | Upgrade
|
| Other Non Operating Income (Expenses) | 54.5 | 31.75 | 0.33 | 8.57 | 12.42 | Upgrade
|
| EBT Excluding Unusual Items | -753.6 | 1,244 | 1,941 | 2,388 | 1,322 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 2.44 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -3.78 | -12.62 | -5.11 | -2.43 | Upgrade
|
| Asset Writedown | - | - | - | -17.47 | - | Upgrade
|
| Other Unusual Items | 9.9 | 115.28 | - | - | - | Upgrade
|
| Pretax Income | -743.7 | 1,358 | 1,928 | 2,366 | 1,320 | Upgrade
|
| Income Tax Expense | 35.8 | 387.95 | 505.41 | 817.72 | 389.52 | Upgrade
|
| Earnings From Continuing Operations | -779.5 | 970.04 | 1,423 | 1,548 | 930.46 | Upgrade
|
| Minority Interest in Earnings | 42.1 | 14.56 | - | - | - | Upgrade
|
| Net Income | -737.4 | 984.6 | 1,423 | 1,548 | 930.46 | Upgrade
|
| Net Income to Common | -737.4 | 984.6 | 1,423 | 1,548 | 930.46 | Upgrade
|
| Net Income Growth | - | -30.78% | -8.11% | 66.37% | 285.80% | Upgrade
|
| Shares Outstanding (Basic) | 87 | 92 | 92 | 92 | 92 | Upgrade
|
| Shares Outstanding (Diluted) | 87 | 92 | 92 | 92 | 92 | Upgrade
|
| Shares Change (YoY) | -5.53% | 0.01% | 0.11% | - | - | Upgrade
|
| EPS (Basic) | -8.46 | 10.68 | 15.44 | 16.80 | 10.10 | Upgrade
|
| EPS (Diluted) | -8.46 | 10.67 | 15.42 | 16.80 | 10.10 | Upgrade
|
| EPS Growth | - | -30.79% | -8.21% | 66.37% | 285.80% | Upgrade
|
| Free Cash Flow | -2,612 | -2,706 | -284.23 | 485.04 | 53.73 | Upgrade
|
| Free Cash Flow Per Share | -29.97 | -29.33 | -3.08 | 5.26 | 0.58 | Upgrade
|
| Dividend Per Share | 0.200 | 1.500 | 2.250 | 1.500 | 1.500 | Upgrade
|
| Dividend Growth | -86.67% | -33.33% | 50.00% | - | 400.00% | Upgrade
|
| Gross Margin | 70.08% | 65.86% | 66.07% | 67.90% | 69.06% | Upgrade
|
| Operating Margin | -0.88% | 8.44% | 13.00% | 16.27% | 12.20% | Upgrade
|
| Profit Margin | -4.43% | 5.42% | 8.53% | 10.05% | 7.49% | Upgrade
|
| Free Cash Flow Margin | -15.69% | -14.89% | -1.70% | 3.15% | 0.43% | Upgrade
|
| EBITDA | 992.6 | 2,124 | 2,719 | 2,999 | 2,006 | Upgrade
|
| EBITDA Margin | 5.96% | 11.68% | 16.30% | 19.46% | 16.16% | Upgrade
|
| D&A For EBITDA | 1,138 | 589.92 | 549.88 | 492.24 | 492.15 | Upgrade
|
| EBIT | -145.8 | 1,534 | 2,169 | 2,507 | 1,514 | Upgrade
|
| EBIT Margin | -0.88% | 8.44% | 13.00% | 16.27% | 12.20% | Upgrade
|
| Effective Tax Rate | - | 28.57% | 26.21% | 34.56% | 29.51% | Upgrade
|
| Revenue as Reported | 16,704 | 18,271 | 16,709 | 15,431 | 12,446 | Upgrade
|
| Advertising Expenses | - | 999.09 | 715.66 | 458.47 | 435.49 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.